SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001136261-19-000220
Filing Date
2019-08-15
Accepted
2019-08-15 16:32:03
Documents
6
Effectiveness Date
2019-08-15

Document Format Files

Seq Description Document Type Size
1 S-8 s8body.htm S-8 63591
2 FORM OF STOCK OPTION AGREEMENT UNDER THE SEELOS THERAPEUTICS, INC. 2019 INDUCEME exh4-3.htm EX-4.3 39156
3 OPINION exh5-1.htm EX-5.1 6661
4 CONSENT exh23-1.htm EX-23.1 1193
5 CONSENT exh23-2.htm EX-23.2 1555
6 LOGO image4055.jpg GRAPHIC 64418
  Complete submission text file 0001136261-19-000220.txt   202168
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233305 | Film No.: 191030645
SIC: 2834 Pharmaceutical Preparations